Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:6:p28
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 6 (pt 28/36)
Character Range: 389117–392479

and primary pack are labelled with the following statements:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) WARNING – This product contains ingredients which may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye;

        written in letters not less than 1.5 mm in height.
    NITROPHENOLS, ortho, meta and para, except when separately specified in these Schedules.
    NITROPRUSSIDES in preparations containing 2.5% or less of nitroprussides except when included in Schedule 4.
    NITROUS OXIDE except when included in Schedule 4.
    NITROXYNIL.
    NONOXINOL 9 except:

       (a) when included in Schedule 5; or

       (b) in preparations containing 25% or less of nonoxinol 9 when labelled with the statements:

          (i) IRRITANT; and

          (ii) Avoid contact with eyes; or

       (c) in preparations containing 12.5% or less of nonoxinol 9; or

       (d) in preparations for human use.
    1‑OCTEN‑3‑OL except in preparations containing 5% or less of 1‑octen‑3‑ol.
    OCTHILINONE except in paints, jointing compounds and sealants containing 1% or less of octhilinone calculated on the non‑volatile content.
    N‑(N‑OCTYL)‑2‑PYRROLIDONE except:

       (a) when included in Schedule 5; or

       (b) in preparations containing 25% or less of designated solvents.
    OLAQUINDOX except in preparations containing 10% or less of olaquindox.
    N‑OLEYL‑1,3‑DIAMINOPROPANE.
    OMETHOATE in preparations containing 30% or less of omethoate except when included in Schedule 5.
    OXADIAZON.
    OXALIC ACID except

       (a) in dental care preparations, including mouthwashes, containing 3% or less of soluble salts of oxalic acid; or

       (b) its insoluble salts.
    OXYCLOZANIDE.
    PAECILOMYCES LILACINUS STRAIN 251.
    PALMITOYLETHANOLAMIDE (excluding derivatives) except:

       (a) in preparations for therapeutic use; or

       (b) in preparations for dermal cosmetic use containing 1% or less of palmitoylethanolamide.
    PARAFORMALDEHYDE (excluding its derivatives) in preparations containing 0.05% or more of free formaldehyde except:

       (a) for human therapeutic use; or

       (b) in oral hygiene preparations; or

       (c) in nail hardener cosmetic preparations containing 5% or more of free formaldehyde; or

       (d) in nail hardener cosmetic preparations containing 0.2% or less of free formaldehyde when labelled with the statement:

           PROTECT CUTICLES WITH GREASE OR OIL; or

       (e) in all other cosmetic preparations; or

       (f) in other preparations containing 0.2% or less of free formaldehyde when labelled with the warning statement:

           CONTAINS FORMALDEHYDE.
    PARATHION‑METHYL in aqueous preparations containing 45% or less of microencapsulated parathion‑methyl.
    PARBENDAZOLE.
    PEBULATE.
    PENNYROYAL OIL except:

       (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or

       (b) in preparations other than medicines for human